首页 | 本学科首页   官方微博 | 高级检索  
     

Dll4分子在肝细胞癌中的表达及其与预后的关系
引用本文:闫向勇1,党 政2,魏千程1,李 俊1,蔺彩娟1,燕忠生1. Dll4分子在肝细胞癌中的表达及其与预后的关系[J]. 现代肿瘤医学, 2019, 0(18): 3264-3267. DOI: 10.3969/j.issn.1672-4992.2019.18.023
作者姓名:闫向勇1  党 政2  魏千程1  李 俊1  蔺彩娟1  燕忠生1
作者单位:1.中国人民解放军联勤保障部队第940医院中医康复科;2.肝胆外科,甘肃 兰州 730050
基金项目:兰州市科技计划项目(编号:2018-3-60)
摘    要:目的:探讨Dll4分子在肝癌组织中的表达及其在肝癌术后患者预后中的作用。方法:采用免疫组化方法检测28例肝癌组织以及癌旁组织中Dll4的表达水平。并结合患者随访情况分析Dll4蛋白表达水平与肝细胞癌术后患者预后的关系。结果:免疫组化结果显示Dll4蛋白表达主要定位于细胞浆,肝癌组织中Dll4蛋白表达明显高于癌旁组织(P<0.05)。Cox模型多因素分析结果显示肝癌合并微血管侵犯与Dll4蛋白表达情况是患者预后的独立危险因素。结论:Dll4分子高表达的肝癌术后患者相对于低表达患者预后更差,术后生存时间更短。可能成为肝细胞癌新的预后标志物。

关 键 词:肝癌  Dll4分子  生存分析  预后

The relationship between Dll4 expression and prognosis of hepatocellular carcinoma
Yan Xiangyong1,Dang Zheng2,Wei Qiancheng1,Li Jun1,Lin Caijuan1,Yan Zhongsheng1. The relationship between Dll4 expression and prognosis of hepatocellular carcinoma[J]. Journal of Modern Oncology, 2019, 0(18): 3264-3267. DOI: 10.3969/j.issn.1672-4992.2019.18.023
Authors:Yan Xiangyong1  Dang Zheng2  Wei Qiancheng1  Li Jun1  Lin Caijuan1  Yan Zhongsheng1
Affiliation:1.Department of Traditional Chinese Medicine;2.Department of Hepatobiliary Surgery,Hospital 940 of PLA Joint Logistics Support Force,Gansu Lanzhou 730050,China.
Abstract:Objective:To explore the potential role of Dll4 expression in hepatocellular carcinoma (HCC) tissue and prognosis of postoperative patients with HCC.Methods:A total of 28 HCC tissue samples and the corresponding adjacent tissues were examined by immunohistochemistry.The expression level of Dll4 was combined with the follow-up of patients to analyze the relationship between Dll4 protein expression level and prognosis of patients with HCC.Results:Dll4 protein expression was mainly localized in cytoplasm,and the expression of Dll4 protein in cancer tissues was significantly higher than that in the adjacent tissues (P<0.05).The multivariate analysis of Cox model showed that HCC with microvascular invasion and Dll4 protein expression were independent risk factors for prognosis.Conclusion:Postoperative patients with high expression of Dll4 have a worse prognosis than patients with low expression.The survival time after surgery is shorter.Dll4 may be a new prognostic marker for HCC.
Keywords:hepatocellular carcinoma   Dll4   survival analysis   prognosis
点击此处可从《现代肿瘤医学》浏览原始摘要信息
点击此处可从《现代肿瘤医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号